Elanco

Last updated

Elanco Animal Health Incorporated
Type Public
Industry Pharmaceutical (animal)
Founded1954  OOjs UI icon edit-ltr-progressive.svg
Headquarters Greenfield, Indiana, U.S.
Key people
  • R. David Hoover (Chairman)
  • Jeff Simmons (CEO)
Products Pharmaceutical drugs (animal)
RevenueIncrease2.svg US$4.765 billion (2021) [1]
Increase2.svg –US$0.567 billion (2021) [1]
Increase2.svg –US$0.472 billion (2021) [1]
Total assets Decrease2.svg US$16.483 billion (2021) [1]
Total equity Decrease2.svg US$7.538 billion (2021) [1]
Number of employees
10,200 (2021) [2]
Website elanco.com

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. [3]

Contents

History

The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company. [4]

In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health. [4]

In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions. [4]

In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site. [5] In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health. [6] In 2012 the business acquired ChemGen Corp. [7] In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum [8] and Novartis Animal Health for $5.4 billion. In 2016 Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica for $885 million. [9]

In 2013, Elanco made a $100M investment in China Animal Healthcare. [10]

In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics, [11] and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc. [12] In the same year the business announced it would acquire Bayer's animal health business for $7.6 billion. [13] [14]

On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021. [15] [ needs update ]

In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences. [16]

Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars are not registered for sale in Canada. [17] [18]

On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause for reported animal deaths. The EPA limited the collar's registration to five years instead of the normal fifteen years registration, as other pesticides normally receive. Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data. [19]

Acquisitions

Elanco Acquisitions

Related Research Articles

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

<span class="mw-page-title-main">Novartis</span> Swiss-American multinational pharmaceutical corporation

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

<span class="mw-page-title-main">Takeda Pharmaceutical Company</span> Japanese pharmaceutical company

The Takeda Pharmaceutical Company Limited[takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

<span class="mw-page-title-main">AstraZeneca</span> British pharmaceutical company

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

<span class="mw-page-title-main">Eli Lilly and Company</span> American pharmaceutical company

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.

<span class="mw-page-title-main">Boehringer Ingelheim Animal Health</span>

Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

<span class="mw-page-title-main">Thermo Fisher Scientific</span> Provisioner of scientific consumables, equipment, and services

Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).

Inovalon is an American technology company that provides cloud-based tools for healthcare.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

<span class="mw-page-title-main">CureVac</span> German bio-pharmaceutical company

CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee. CureVac has approximately 375 employees since May 2018.

<span class="mw-page-title-main">Olivier Brandicourt</span> French businessman

Olivier Brandicourt is a French business executive and physician, and the former chief executive officer of Sanofi.

<span class="mw-page-title-main">Cancer Breakthroughs 2020</span>

Cancer Breakthroughs 2020, also known as Cancer Moonshot 2020 is a coalition with the goal of finding vaccine-based immunotherapies against cancer. By pooling the resources of multinational pharmaceutical, biotechnology companies, academic centers and oncologists, it intends to create access to over 60 novel and approved agents under exploration in the war against cancer and is expected to enable rapid testing of novel immunotherapy combination protocols. The initiative is being managed by a consortium of companies called The National Immunotherapy Coalition.

Woodruff, previously known as Woodruff Sweitzer, is an advertising agency founded in Columbia, Missouri by Terry Woodruff. Woodruff has worked with various national and regional clients including Bayer HealthCare's Animal Health Division, Arysta LifeScience Corp, Diamond Pet Foods, Missouri Farm Bureau Insurance, and the University of Missouri's Athletics Department. In 2007, Woodruff was selected to produce Boone County National Bank's 150th anniversary campaign, which led to Woodruff working with its parent company, Central Bancompany.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. 1 2 3 4 5 "2021 Annual Report" (PDF). Elanco. 31 December 2021. Retrieved 17 March 2023.
  2. ↑ "Elanco Animal Health Company Profile".
  3. ↑ "Elanco Moving Global HQ to Indy".
  4. 1 2 3 "About Elanco | Solutions for Protecting and Enhancing Animal Health". www.elanco.com.
  5. ↑ "Lilly to Acquire European Rights to Pfizer Animal Health Assets". www.elanco.com.
  6. ↑ "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". www.elanco.com.
  7. ↑ "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". www.elanco.com. 24 January 2012. Archived from the original on 17 July 2020. Retrieved 17 July 2020.
  8. ↑ "Elanco Announces Agreement to Acquire Lohmann Animal Health". www.elanco.com.
  9. ↑ "Lilly Finalizes Novartis Animal Health Acquisition". www.elanco.com.
  10. ↑ "Elanco invests in China Animal Healthcare". www.feedstuffs.com. 12 April 2013.
  11. ↑ "Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus". www.elanco.com.
  12. ↑ "Elanco Announces Acquisition of Prevtec Microbia Swine Vaccine Company". www.elanco.com.
  13. ↑ "Elanco to divest brands, forgo Canadian rights for Bayer's unit deal". Reuters. 14 July 2020 – via uk.reuters.com.
  14. ↑ "Elanco Animal Health wins approval to buy Bayer unit". Reuters. 15 July 2020 – via uk.reuters.com.
  15. ↑ Burris, Alexandria. "Former GM stamping plant will be home to Elanco Animal Health headquarters". The Indianapolis Star. Retrieved 5 December 2020.
  16. ↑ "Elanco Closes Acquisition of Kindred Biosciences".
  17. ↑ "Lawmakers say this flea collar should be recalled after 2,500 pet deaths". FOX13 News. 16 June 2022. Retrieved 16 June 2022.
  18. ↑ Novak, Matt (16 June 2022). "Seresto Flea Collars Might Be Banned After Lawmakers Grill CEO". Gizmodo. Retrieved 16 June 2022.
  19. ↑ Hettinger, Johnathan (14 July 2023). "EPA rules popular Seresto flea collar stays on the market, adds more reporting requirements". USA Today . Retrieved 8 August 2023.
  20. ↑ "Eli Lilly and Company Announces Acquisition of Ivy Animal Health". PRNewswire. 25 May 2007.
  21. ↑ "Lilly to Acquire European Rights to Pfizer Animal Health Assets". PRNewswire. 8 March 2010.
  22. ↑ "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". PRNewswire. 14 March 2011.
  23. ↑ "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". PRNewswire. 24 January 2012.
  24. ↑ "Elanco Announces Agreement to Acquire Lohmann Animal Health". PRNewswire. 24 February 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.